Letter from the Editor

Immunopharmacol Immunotoxicol. 2017 Feb;39(1):1. doi: 10.1080/08923973.2017.1264166.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies / adverse effects
  • Antibodies / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Immunotherapy / adverse effects
  • Immunotherapy / methods*
  • Periodicals as Topic

Substances

  • Antibodies